AKT1 and liver cancer: found through a study of 291 liver cancer patients that the Fuzheng Jiedu Xiaoji formula restrained the migration and proliferation of liver cancer cells via the AKT/CyclinD1/p21/p27 pathway, improved patient survival, and reduced mortality (145).